Elanco Animal Health (NYSE:ELAN – Get Free Report) and LifeStance Health Group (NASDAQ:LFST – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
Profitability
This table compares Elanco Animal Health and LifeStance Health Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Elanco Animal Health | 9.68% | 7.04% | 3.45% |
| LifeStance Health Group | -1.23% | -1.11% | -0.76% |
Valuation & Earnings
This table compares Elanco Animal Health and LifeStance Health Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Elanco Animal Health | $4.44 billion | 2.21 | $338.00 million | $0.86 | 22.99 |
| LifeStance Health Group | $1.25 billion | 1.57 | -$57.44 million | ($0.05) | -101.00 |
Elanco Animal Health has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current recommendations for Elanco Animal Health and LifeStance Health Group, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elanco Animal Health | 0 | 3 | 6 | 2 | 2.91 |
| LifeStance Health Group | 2 | 0 | 5 | 2 | 2.78 |
Elanco Animal Health currently has a consensus target price of $19.14, indicating a potential downside of 3.17%. LifeStance Health Group has a consensus target price of $8.50, indicating a potential upside of 68.32%. Given LifeStance Health Group’s higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than Elanco Animal Health.
Insider & Institutional Ownership
97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility & Risk
Elanco Animal Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.
Summary
Elanco Animal Health beats LifeStance Health Group on 12 of the 14 factors compared between the two stocks.
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
About LifeStance Health Group
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
